-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hydroxychloroquine (HCQ) has been shown to reduce the risk of SLE (lupus) episodes, lupus nephritis (LN), kidney damage and death from L.
It was hypothesized that previous studies were insufficient to determine the improvement in pregnancy outcomes associated with HC.
Search flowchart for identifying eligible groups:
Methods: Eligible studies included prospectively collected pregnancies in women with lupu.
Queue Features:
Results: Seven cohorts provided 938 pregnancies in 804 wome.
Forest plot of effects of hydroxychloroquine (HCQ) use on pregnancy outcomes in women with SLE:
In conclusion, this large study of prospectively collected lupus pregnancies showed that women who continued to use HCQ throughout pregnancy had reduced lupus activity with no impairment of pregnancy outcome.
References: Clowse MEB, Eudy AM, Balevic S, Sanders-Schmidler G, Kosinski A, Fischer-Betz R, Gladman DD, Molad Y, Nalli C, Mokbel A, Tincani A, Urowitz M, Bay C, van Noord M, Petri .